HOUSTON (AP) — HOUSTON (AP) — Aravive, Inc. (ARAV) on Wednesday reported a loss of $29.1 million in its fourth quarter.

On a per-share basis, the Houston-based company said it had a loss of 46 cents.

The biopharmaceutical company posted revenue of $1.5 million in the period.

For the year, the company reported that its loss widened to $76.3 million, or $2.10 per share. Revenue was reported as $9.1 million.

The company's shares closed at $1.68. A year ago, they were trading at $2.01.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARAV at https://www.zacks.com/ap/ARAV

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News